Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:administeredBy |
subcutaneous injection
|
| gptkbp:approvalYear |
2005
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
A10BX05
|
| gptkbp:contraindication |
gastroparesis
hypoglycemia unawareness |
| gptkbp:drugClass |
amylin analogue
|
| gptkbp:genericName |
pramlintide
|
| https://www.w3.org/2000/01/rdf-schema#label |
Symlin
|
| gptkbp:manufacturer |
gptkb:AstraZeneca
|
| gptkbp:mechanismOfAction |
slows gastric emptying
suppresses glucagon secretion promotes satiety |
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
subcutaneous
|
| gptkbp:sideEffect |
gptkb:hypoglycemia
nausea anorexia |
| gptkbp:usedFor |
gptkb:diabetes_mellitus_type_2
diabetes mellitus type 1 |
| gptkbp:bfsParent |
gptkb:Amylin_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|